DHEA
DHEA is a pharmaceutical drug with 32 clinical trials. Currently 1 active trials ongoing. Historical success rate of 78.3%.
Success Metrics
Based on 18 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
5
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
72.0%
18 of 25 finished
28.0%
7 ended early
1
trials recruiting
32
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial
The Effects of Fluoxetine and/or DHEA
Effects of DHEA and Exercise on Bone Marrow Fat in Postmenopausal Women
DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women
Effectiveness of Adjuvant Supplements Prior to in IVF
Clinical Trials (32)
Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial
The Effects of Fluoxetine and/or DHEA
Effects of DHEA and Exercise on Bone Marrow Fat in Postmenopausal Women
DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women
Effectiveness of Adjuvant Supplements Prior to in IVF
Neurosteroids in PTSD - Biomarkers to Therapeutics
Effect of Testosterone Treatment on Embryo Quality
Dehydroepiandrosterone (DHEA)Supplementation Pre-IVF(In Vitro Fertilization) Cycles
DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer
DHEA in Synovial Sarcoma Patients
Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve
Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy
Testosterone Gel in Poor Responders Undergoing IVF
DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy
A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)
Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response
DHEA Versus Placebo in Women With Poor Ovarian Response
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 32